4) Group JCO: National Cancer Institute Common Toxicity Criteria (NCI-CTC Version 2.0, April 30, 1999). http://www.jcog.jp/SHIRYOU/CTCJ_v20revised2001_09.pdf
6) Handbook of Cancer Chemotherapy. (ed. 5th edition), (Skeel RT ed. ).
7) Ratain MJ: Pharmacology of Cancer Chemotherapy. (ed. 6th Edition), (Devita VT, Hellman S, Rosenberg SA, eds. ). Chapter 19. Principles and Practice of Oncotogy. Lippincott Williams & Wilkins, 2001.
8) O'Grady NP, Barie PS, Bartlett JG et al.: Practice guidelines for evaluating new fever incritically ill adult patients. Task Force of the Society of Critical Care Medicine and the Infectious Diseases Society of America. Clin Infect Dis 1998, 26:1042-1059.
14) Segal BH, Walsh TJ, Holland SM: Chapter 54: Infections in the Cancer Patient. (ed. 6th Edition), (Devita VT, Hellman S, Rosenberg SA, eds. ) Principles and Practice of Oncology. Lippincott Williams & Wilkins, 2001.
15) Dykewicz CA, Kaplan JE: Guidelines for preventing apportunistic infections among hematopoietic stem cell transplant recipients. http://www.cdc.gov/mmwr/PDF/rr/rr4910.pdf
16) Pizzo PA, Purvis DS, Waters C: Microbiological evaluation of food items. For patients undergoing gastrointestinal decontamination and protected isolation. J Am Diet Assoc 1982, 81:272-279.
17) Uzun O, Anaissie EJ: Antifungal prophylaxis in patients with hematologic malignancies: a reappraisal. Blood 1995, 86:2063-2072.
24) Sterner S, Plummer DW, Clinton J, Ruiz E: A comparison of the supraclavicular approach and the infraclavicular approach for subclavian vein catheterization. Ann Emerg Med 1986, 15:421-424.
25) Hughes WT, Armstrong D, Bodey GP et al.: 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002, 34:730-751.
26) Hughes WT, Armstrong D, Bodey GP et al.: 1997 guidelines for the use of antimicrobialagents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis 1997, 25:551-573.
28) EORTC International Antimicrobial Therapy Cooperative Group: Empiric antifungal therapy in febrile granulocytopenic patients. Am J Med 1989, 86:668-672.
36) Herbrecht R, Denning DW, Patterson TF et al.: Voriconazole versus amphotericin B forprimary therapy of invasive aspergillosis. N Engl J Med 2002, 347:408-415.
39) Munoz L, Balmana J, Martino R, Sureda A, Rabella N, Brunet S: Abdominal pain as the initial symptom of visceral varicella zoster infection in hematopoietic stem cell transplant recipients, Med Clin (Barc)1998, 111:19-22.
42) Petros WP: Pharmacokinetics and administration of colony-stimulating factors. Pharmacotherapy 1992, 12:32S-38S.
49) Evidence-based medicine. A new approach to teachingthe practice of medicine. Evidence-Based Medicine Working Group. JAMA 1992, 268:2420-2425.
51) Evidence Based cardiology. (ed. 2nd Edition). (Yusuf S, Cairns JA, Camm AJ, Fallen EL, Gersh BJ eds. )